Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03303196 · ClinicalTrials.gov registry record · NA

Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes

A NA study of Diabetes and Hyperinsulinism, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03303196 is a NA study of Diabetes and Hyperinsulinism that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 10 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03303196, a NA study of Diabetes and Hyperinsulinism, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study designed to determine if the bihormonal bionic pancreas provides improved blood glucose control, compared to the current standard of care, in individuals with hyperinsulinism who developed diabetes after having a pancreatectomy.

Interventions

  • DEVICE Bihormonal Bionic Pancreas

Study Locations (1)

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2018-04-09
Est. Completion 2019-09-30
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT03303196

The ClinicalTrials.gov registry entry for NCT03303196 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Bihormonal Bionic Pancreas is the first listed.

NCT03303196 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03303196 about?

NCT03303196 is a clinical study titled "Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes". This is a pilot study designed to determine if the bihormonal bionic pancreas provides improved blood glucose control, compared to the current standard of care, in individuals with hyperinsulinism who developed diabetes after having a pancreatectomy.

What is the current status of trial NCT03303196?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-04-09. Estimated completion is 2019-09-30.

What conditions does trial NCT03303196 study?

This clinical trial studies the following conditions: Diabetes, Hyperinsulinism, Pancreatic Diseases, Pancreatectomy; Hyperglycemia.

What interventions are being tested in trial NCT03303196?

The interventions under investigation include: Bihormonal Bionic Pancreas (DEVICE).

Who is sponsoring clinical trial NCT03303196?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03303196 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.